These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 30696399)
1. Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function. Tremblay-McLean A; Coenraads S; Kiani Z; Dupuy FP; Bernard NF BMC Immunol; 2019 Jan; 20(1):8. PubMed ID: 30696399 [TBL] [Abstract][Full Text] [Related]
2. Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells. Tremblay-McLean A; Bruneau J; Lebouché B; Lisovsky I; Song R; Bernard NF Viruses; 2017 Oct; 9(10):. PubMed ID: 29023371 [TBL] [Abstract][Full Text] [Related]
3. Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions. Jung D; Baek YS; Lee IJ; Kim KY; Jang H; Hwang S; Jung J; Moon YW; Park KS; Choi YS; An HJ J Exp Clin Cancer Res; 2021 Oct; 40(1):333. PubMed ID: 34686187 [TBL] [Abstract][Full Text] [Related]
4. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation. Gooneratne SL; Center RJ; Kent SJ; Parsons MS Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083 [TBL] [Abstract][Full Text] [Related]
5. Coordinated regulation of NK receptor expression in the maturing human immune system. Strauss-Albee DM; Horowitz A; Parham P; Blish CA J Immunol; 2014 Nov; 193(10):4871-9. PubMed ID: 25288567 [TBL] [Abstract][Full Text] [Related]
6. p40 molecule regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes. Poggi A; Tomasello E; Revello V; Nanni L; Costa P; Moretta L Int Immunol; 1997 Sep; 9(9):1271-9. PubMed ID: 9310830 [TBL] [Abstract][Full Text] [Related]
7. Functional analysis of NK cell subsets activated by 721.221 and K562 HLA-null cells. Lisovsky I; Isitman G; Bruneau J; Bernard NF J Leukoc Biol; 2015 Apr; 97(4):761-7. PubMed ID: 25713086 [TBL] [Abstract][Full Text] [Related]
8. HLA-F on HLA-Null 721.221 Cells Activates Primary NK Cells Expressing the Activating Killer Ig-like Receptor KIR3DS1. Kiani Z; Dupuy FP; Bruneau J; Lebouché B; Zhang CX; Jackson E; Lisovsky I; da Fonseca S; Geraghty DE; Bernard NF J Immunol; 2018 Jul; 201(1):113-123. PubMed ID: 29743316 [TBL] [Abstract][Full Text] [Related]
9. NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival. Gras Navarro A; Kmiecik J; Leiss L; Zelkowski M; Engelsen A; Bruserud Ø; Zimmer J; Enger PØ; Chekenya M J Immunol; 2014 Dec; 193(12):6192-206. PubMed ID: 25381437 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory Receptor Crosslinking Quantitatively Dampens Calcium Flux Induced by Activating Receptor Triggering in NK Cells. Ganesan S; Höglund P Front Immunol; 2018; 9():3173. PubMed ID: 30693005 [TBL] [Abstract][Full Text] [Related]
11. Listeria monocytogenes infection differentially affects expression of ligands for NK cells and NK cell responses, depending on the cell type infected. Shegarfi H; Rolstad B; Kane KP; Nestvold J J Leukoc Biol; 2018 Mar; 103(3):591-599. PubMed ID: 27106671 [TBL] [Abstract][Full Text] [Related]
12. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma. Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020 [TBL] [Abstract][Full Text] [Related]
13. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions. Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088 [TBL] [Abstract][Full Text] [Related]
14. Intrahepatic and peripheral blood phenotypes of natural killer and T cells: differential surface expression of killer cell immunoglobulin-like receptors. Podhorzer A; Machicote A; Belén S; Lauferman L; Imventarza O; Montal S; Marciano S; Galdame O; Podesta LG; Fainboim L Immunology; 2018 Jun; 154(2):261-273. PubMed ID: 29247515 [TBL] [Abstract][Full Text] [Related]
15. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104. Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142 [TBL] [Abstract][Full Text] [Related]
16. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells. Banerjee P; Feuer G; Barker E J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265 [TBL] [Abstract][Full Text] [Related]
17. Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line. Howell DN; Andreotti PE; Dawson JR; Cresswell P J Immunol; 1985 Feb; 134(2):971-6. PubMed ID: 3871222 [TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes. Schleypen JS; Von Geldern M; Weiss EH; Kotzias N; Rohrmann K; Schendel DJ; Falk CS; Pohla H Int J Cancer; 2003 Oct; 106(6):905-12. PubMed ID: 12918068 [TBL] [Abstract][Full Text] [Related]
19. Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG). García-López R; de la Morena-Barrio ME; Alsina L; Pérez-Dueñas B; Jaeken J; Serrano M; Casado M; Hernández-Caselles T PLoS One; 2016; 11(7):e0158863. PubMed ID: 27415628 [TBL] [Abstract][Full Text] [Related]
20. HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation. Duygu B; Olieslagers TI; Groeneweg M; Voorter CEM; Wieten L Front Immunol; 2021; 12():680480. PubMed ID: 34295330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]